World`s 1st Genomic Nutricart - Where Science Meets Nourishment
.png)
Fatty Liver
Fatty liver disease, encompassing both non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH), is characterized by the excessive accumulation of fat in liver cells. This condition can progress to more severe liver damage, including fibrosis, cirrhosis, and liver cancer. Genetics play a significant role in the susceptibility to fatty liver disease, with certain genetic markers being prominently associated with its development and progression. Two key genes linked to fatty liver disease are PNPLA3 and PEMT:
PNPLA3 Gene
Variants in the PNPLA3 gene, particularly the I148M polymorphism, have been strongly associated with an increased risk of NAFLD and NASH. This variant can alter lipid metabolism in the liver, leading to the accumulation of fat in liver cells. Individuals carrying this variant often exhibit higher liver fat content and elevated liver enzyme levels, making them more susceptible to liver inflammation and damage.
PEMT Gene
The PEMT (phosphatidylethanolamine N-methyltransferase) gene is another significant genetic factor in fatty liver disease. Variants in the PEMT gene can impair the synthesis of phosphatidylcholine, a crucial component of very low-density lipoproteins (VLDL) that are responsible for exporting fat from the liver. Deficiency in phosphatidylcholine production can lead to the retention and accumulation of fat within liver cells, increasing the risk of NAFLD.
Diet can significantly impact gene variants associated with fatty liver disease. For individuals with the PNPLA3 gene variant, a low-carbohydrate diet, rich in omega-3 fatty acids, and high in fiber can help reduce liver fat accumulation and improve lipid metabolism. For those with the PEMT gene variant, increasing choline-rich foods, ensuring adequate B vitamins, and consuming healthy fats can support phosphatidylcholine synthesis and mitigate fat buildup in the liver.